| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089897 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 04/28/2005 | US20050089520 Antibody stimulating il-ira production |
| 04/28/2005 | US20050089516 Artificial skin; mixture of protein and serine protease inhibitor |
| 04/28/2005 | US20050089499 Forming a fermentation broth from plants inoculation with microorganisms and fermenttion to produce active component for use on skin and hair |
| 04/28/2005 | US20050089495 Transdermal transport of compounds |
| 04/28/2005 | US20050089487 Protective coatings for skin, hair, for use as ultravilotet radiation filters in cosmetic or pharmaceutical preparations for protecting human skin or human hair against solar rays |
| 04/28/2005 | US20050087705 Radiation protector and utilization thereof |
| 04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 04/28/2005 | CA2542290A1 Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof |
| 04/28/2005 | CA2541405A1 The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
| 04/28/2005 | CA2540859A1 Topical compositions comprising telmesteine for treating dermatological disorders |
| 04/28/2005 | CA2539059A1 Novel ligand activating receptors rars used for human medicine and cosmetics |
| 04/27/2005 | EP1525884A1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525880A1 Cosmetic or dermatologic O/W emulsion having a stable pH |
| 04/27/2005 | EP1525204A1 Phenylalanine enamide derivatives |
| 04/27/2005 | EP1525201A1 Bicyclic piperidine derivatives as antagonists of the ccr1 chemokine receptor |
| 04/27/2005 | EP1525200A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/27/2005 | EP1525199A1 Substituted thienyl-hydroxamic acids as histone deacetylase inhibitors |
| 04/27/2005 | EP1525191A2 Novel method for preparing styryl pyrazole, isoxazole and isothiazole derivatives |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1524980A1 Phenylalanine enamide derivatives containing a spiro[3.5]non-1-ene ring for use as integrin inhibitors |
| 04/27/2005 | EP1524974A2 Transcription factor modulating compounds and methods of use thereof |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1325010B1 Substituted 3.4-dihydro-pyrimido [1,2-a]pyrimidines and 3.4-dihydropyrazino [1,2-a]pyrimidines |
| 04/27/2005 | EP1144411B1 Antihistaminic spiro compounds |
| 04/27/2005 | EP1139974A4 Soy depigmenting and skin care compositions |
| 04/27/2005 | EP1040098B1 Integrin receptor antagonists |
| 04/27/2005 | EP1037596B1 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 04/27/2005 | EP0994853B1 A monoether of probucol and methods for the inhibition of the expression of vcam-1 |
| 04/27/2005 | EP0900561B1 Compositions promoting collagen production |
| 04/27/2005 | EP0838453B1 Heterocyclic carboxylic acid derivatives and drugs containing the same |
| 04/27/2005 | CN1610828A Drugs for ameliorating itch, rough skin or hypersensitive skin or for whitening via inhibition of the production and release of stem cell |
| 04/27/2005 | CN1610691A 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it |
| 04/27/2005 | CN1610675A Benzothiazole- and benzoxazole-4, 7-dione derivatives and their use as CDC25 phosphatase inhibitors |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610670A 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 04/27/2005 | CN1610668A Substituted propane-1, 3-diamine derivatives and the pharmaceutical use |
| 04/27/2005 | CN1610664A 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 04/27/2005 | CN1610564A Compositions and methods of using collajolie |
| 04/27/2005 | CN1610563A Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant topical ointments |
| 04/27/2005 | CN1610552A Antipruritics |
| 04/27/2005 | CN1610550A Pharmaceutical formulations comprising an immune response modifier |
| 04/27/2005 | CN1608693A Ginseng and American ginseng prepn containing arbutin and the prepn process |
| 04/27/2005 | CN1608669A Filming aerosol for treating tinea coporis, tinea manuum and tinea pedis |
| 04/27/2005 | CN1608657A Frostbite treating Chinese medicine prepn |
| 04/27/2005 | CN1608651A Skin care cosmetic bolus for treating facial acne whelk and chloasma |
| 04/27/2005 | CN1608647A Acne treating medicine |
| 04/27/2005 | CN1608638A Blood cleaning metabolism bolus |
| 04/27/2005 | CN1608632A Steam distillate from soybean and its composition |
| 04/27/2005 | CN1608630A New use of hydrazine hydrate in treating tinea unguium |
| 04/27/2005 | CN1608625A Use and medicine of 4-dedimethylamino tetracycline and its derivative in treating skin diseases |
| 04/27/2005 | CN1608615A Fibrauretine-amino acid fluid for transfusion and its production process |
| 04/27/2005 | CN1608613A Fibrauretine powder for injection and its production process |
| 04/27/2005 | CN1608609A Quickly acting hair restorer and its compounding process |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198844C Process of high purity albumin production |
| 04/27/2005 | CN1198820C N-substituted nitrogen heterocyclic compound |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198649C Drug composition containing PGD2 antagonists for curing inhibitor |
| 04/27/2005 | CN1198646C Identification of unique binding interactions between certain antibodies and the human B7.1 and B7.2 co-stimulatory antigens |
| 04/27/2005 | CN1198637C Health cosmetic composition |
| 04/27/2005 | CN1198632C Distillate of medicinal herbs for treating skin disease |
| 04/27/2005 | CN1198628C Conditioned cell culture medium compositions and method of use |
| 04/27/2005 | CN1198627C Activator and inhibitor of profibrinolysin and agent of external use for skin for mating it |
| 04/27/2005 | CN1198588C Multilayer emulsion for stabilization of effective component on dermatology and externally used preparation using it |
| 04/27/2005 | CN1198576C Skin care compositions contg. combination of skin care actives |
| 04/26/2005 | US6884808 Acids and salts such as 4-(4-(2-(2-(5,6,7,8-Tetrahydro-5,5,8, 8-tetramethylquinoxalyl))pyrrolyl))benzoic acid, used retinoic acid receptor agonists for the prophylaxis of cancer, skin disorders, asthma, alopecia or autoimmune diseases |
| 04/26/2005 | US6884807 3-bicyclic carbocyclic group substituted quinuclidine derivatives, which are cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptor and transporters |
| 04/26/2005 | US6884806 Treatment of rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration, tumor metastasis, periodontal disease, bone disease |
| 04/26/2005 | US6884802 Phenanthridines substituted in position 6 by a mono, bi- or tricyclic heteroaryl radical; cyclic nucleotidephosphoesterase (PDE4) inhibitor and useful for treating respiratory system disorders |
| 04/26/2005 | US6884800 Nitrogen compounds such as 10-Chloro-3-imidazol-1-yl-2,3-dihydro-1H-pyrido(3,2,1-kl)phenothiazine, used for prophylaxis of respiratory system and skin disorders, autoimune diseases, tumors or atherosclerosis and AIDS |
| 04/26/2005 | US6884795 Pharmaceutical compositions and uses for androst-5-ene-3β, 17β-diol |
| 04/26/2005 | US6884785 Compositions and methods for the treatment or prevention of autoimmune diabetes |
| 04/26/2005 | US6884772 Administering endothelins or agonists as drugs or cosmetics for hair removal or wool harvesting |
| 04/26/2005 | US6884425 Adapted for improving skin ageing and/or photoageing signs, which cutaneous signs are directly a result of a chronic micro-inflammatory process induced by repeated UV exposures |
| 04/26/2005 | CA2255222C Use of phloroglucinol in a composition |
| 04/26/2005 | CA2144728C Method of treating premenstrual syndrome symptomatology with vitamin d or vitamin d and calcium |
| 04/21/2005 | WO2005035762A1 Cytokine involved in epithelial-mesenchymal transition |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005035534A1 Heterocyclic bicyclo ring and heterocyclic tricyclo ring compounds and drugs comprising the same |
| 04/21/2005 | WO2005034970A1 Use of probiotic bacteria in the treatment of infection |
| 04/21/2005 | WO2005034938A1 Collagen productin enhancer and production process and use thereof |
| 04/21/2005 | WO2005034931A1 Pharmaceutical compositions comprising malonamide derivatives for decreasing sebum production |
| 04/21/2005 | WO2005034917A2 Hydrophobic silica-based water powder |
| 04/21/2005 | WO2005034901A1 Use of a combination of cromoglicic acid and/or one of the salts and/or esters thereof and a gelling agent, and cosmetic or pharmaceutical applications thereof |
| 04/21/2005 | WO2005034883A2 A method of healing skin wounds in mammals and a composition therefor |
| 04/21/2005 | WO2005034839A2 Porifera-based therapeutic compositions for treating and preventing skin diseases |
| 04/21/2005 | WO2005010047A3 Antiangiogenic compounds, pharmaceutical composition containing said compounds and the use thereof |
| 04/21/2005 | WO2004108142A3 Inhibitors of tip-1 for treatment tissue damage |
| 04/21/2005 | WO2004072687A3 Method and apparatus for correcting vision using an electro-active phoropter |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | US20050085758 Dilute aqueous solution containing epidermal growth factor in gel |
| 04/21/2005 | US20050085637 Pyrimidine compounds |
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050085541 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050085515 Active compounds with carbamic acid for diseases such as cancer, leukemia, atheriosclerosis, alzheimers disease or arthritis |
| 04/21/2005 | US20050085509 KInase inhibitors; antiarthritic agents; autoimmune diseases; sepsis; cachexia; Alzheimer's disease; antihistamines; thrombosis; glomerulonephritis; inflammatory bowel disorders; crohn's disese; multiple sclerosis; antitumor agents; skin disorders |